Expect Fewer Inhaled Steroids to Be Used in Chronic COPD Patients

February 2017

You'll use more bronchodilators and fewer inhaled corticosteroids for chronic COPD...due to new GOLD guidelines.

Many COPD patients get an inhaled steroid/long-acting beta-agonist combo (Advair, Breo, Symbicort) for persistent symptoms.

But combining two long-acting bronchodilators (Anoro, etc) prevents more exacerbations...and has a lower pneumonia risk than steroid combos.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote